Malingering
Malingering isn’t caused by any physical factors. Rather, it’s the results of someone’s desire to realize a gift or avoid something. That said,
malingering is usually amid real mood and personality disorders, like antisocial mental disorder or major clinical depression.
Malingering may be a diagnosis, but not a psychological condition. It’s often hard to diagnose because doctors don’t want to overlook any real physical or psychological conditions. A doctor will usually start with a radical physical exam and open-ended interview to urge a thought of someone’s overall physical and psychological state. This interview will cover the ways a person’s symptoms impact their lifestyle. A doctor also will attempt to get a timeline of any behavioral, emotional, or social events. They’ll do a follow-up exam to see for inconsistencies between someone’s description of their symptoms and what the doctor finds during an exam. If a doctor concludes that somebody is probably going malingering, they'll reach bent their other doctors, relations, friends, or co-workers for more
information about their health. Unfortunately,
malingering is extremely difficult to detect. Psychologists use a good sort of approaches, including the Minnesota Multiphasic personality assessment 2nd version (MMPI-2). Multiscale inventories and projective measures can also be useful. More precisely, measures like the M test (Beaber, Marston, Michelli, and Mills), the Miller Forensic Assessment of Symptoms Test (M-FAST), and therefore the Structured Inventory of Malingered Symptomatology (SIMS) can all are utilized in an effort to detect malingering.
High Impact List of Articles
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
Relevant Topics in Clinical